Patent details
EP3213746 Title: PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING TAXANE
Basic Information
- Publication number:
- EP3213746
- PCT Application Number:
- KR2015007987
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP158546853
- PCT Publication Number:
- WO2016068457
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING TAXANE
- French Title of Invention:
- COMPOSITION PHARMACEUTIQUE POUR ADMINISTRATION ORALE COMPRENANT UN TAXANE
- German Title of Invention:
- PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR ORALEN VERABREICHUNG MIT TAXAN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 19/01/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 29/01/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 27/12/2023
- Unitary Effect Registration Date:
- 29/01/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 30/07/2015
- Grant date:
- 27/12/2023
- EP Publication Date:
- 06/09/2017
- PCT Publication Date:
- 06/05/2016
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 27/12/2023
- EP B1 Publication Date:
- 27/12/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 30/07/2035
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 20/12/2023
- Name:
- Dae Hwa Pharma. Co., Ltd
- Address:
- 495, Hanu-ro, Hoengseong-eup, Hoengseong-gun Gangwon-do, 225-804, Korea (Republic) (KR)
Inventor
1
- Name:
- SON, Min-Hee
- Address:
- Korea (Republic) (KR)
2
- Name:
- LEE, In-Hyun
- Address:
- Korea (Republic) (KR)
3
- Name:
- PARK, Yeong-Taek
- Address:
- Korea (Republic) (KR)
4
- Name:
- LEE, Seul-Ae
- Address:
- Korea (Republic) (KR)
5
- Name:
- LEE, Han-Koo
- Address:
- Korea (Republic) (KR)
Priority
- Priority Number:
- 20140150173
- Priority Date:
- 31/10/2014
- Priority Country:
- Korea (Republic) (KR)
Classification
- IPC classification:
- A61K 9/48; A61K 9/08; A61K 47/14; A61K 9/107; A61K 31/337; A61P 35/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202352
- Publication date:
- 27/12/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202409
- Publication date:
- 28/02/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202409
- Publication date:
- 28/02/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|